海量财经|“疫苗第一股”万泰生物的九价疫苗,只剩6个月可卖

东方财富网
Oct 27

海报新闻记者沈童报道  10月26日晚间,万泰生物(603392.SH)发布2026年三季报。前三季度,公司营业总收入16.23亿元,同比增长8.29%;归母净利润亏损2.31亿元,而上年同期亏损1.73亿元。  营收在涨,亏损却扩大了。更值得留意的是季度之间的差异:第三季度营收5.74亿元,同比减少12.33%;单季归母净利润亏损1.02亿元,而上年同期只亏了2938.38万元。前三季度那...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10